Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease

Singapore Medical Journal

Volumn 52, Issue 3, 2011, Pages 175-181

  Das, S K ^a   Mukherjee, S ^b   Vasudevan, D M ^b   Balakrishnan, V ^b  

^a VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alcoholic liver disease; Fatty liver; Haemoglobin; Mean corpuscular volume; Platelet count

Indexed keywords

HEMOGLOBIN;

ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NONALCOHOLIC FATTY LIVER; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ADULT; ALCOHOLISM; BIOPSY; BLOOD SEDIMENTATION; BODY WEIGHT; ERYTHROCYTE INDICES; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEMATOCRIT; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PLATELET COUNT; QUESTIONNAIRES;

EID: 79958277007     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Das SK, Balakrishnan V, Vasudevan DM. Alcohol: its health and social impact in India. Natl Med J India 2006; 19:94-9.
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-42.
3. Rehm J, Rehn N, Room R, et al. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res 2003; 9:147-56.
4. Das SK, Mukherjee S, Vasudevan DM. Non-alcoholic fatty liver diseases: an under recognized cause with emerging importance. Current Sci 2006; 90:659-65.
5. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434-8.
6. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67:811-6.
7. Paton A. Asking the right questions. In: Paton A, ed. ABC of Alcohol. London: BMJ Publishing Group, 1994: 41.
8. Das KS, Balakrishnan V, Mukherjee S, Vasudevan DM. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scand J Clin Lab Invest 2008; 68:323-34.
9. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21:17-26.
10. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002; 17:1136-43.
11. Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care 2008; 11:21-6.
12. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45:846-54.
13. van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965; 8:141-87.
14. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-9.
15. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3:628-37.
16. Ogasawara F, Fusegawa H, Haruki Y, et al. Platelet activation in patients with alcoholic liver disease. Tokai J Exp Clin Med 2005; 30:41-8.
17. Costa AC, Ribeiro B, Costa E. [Platelet indices in chronic alcoholic liver disease patients with thrombocytopenia.] Arq Gastroenterol 2007; 44:201-4. Portugese.
18. Gheno G, Magnabosco V, Mazzei G. [Macrocytosis and anemia in chronic alcoholism. Correlation with the results of hepatic needle biopsy.] Minerva Med 1981; 72:1301-6. Italian.
19. Colman N, Herbert V. Hematologic complications of alcoholism: overview. Semin Hematol 1980; 17:164-76.
20. Avşaroglu D, Inal TC, Demir M, et al. Biochemical indicators and cardiac function tests in chronic alcohol abusers. Croat Med J 2005; 46:233-7.
21. Morgan MY, Camilo ME, Luck W, Sherlock S, Hoffbrand AV. Macrocytosis in alcohol-related liver disease: its value for screening. Clin Lab Haematol 1981; 3:35-44.
22. Maruyama S, Hirayama C, Yamamoto S, et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 2001; 138:332-7.
23. Wickramasinghe SN, Corridan B, Hasan R, Marjot DH. Correlations between acetaldehyde-modified haemoglobin, carbohydrate-deficient transferrin (CDT) and haematological abnormalities in chronic alcoholism. Alcohol Alcohol 1994; 29:415-23.
24. Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11:74-80.
25. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107:1103-9.
26. Conte D, Bolzoni P, Fraquelli M, Bodini P, Velio P. Nonalcoholic steatohepatitis. Report of five cases and review of the literature. Ital J Gastroenterol 1995; 27:363-5.
27. Pinto HC, Baptista A, Camilo ME, et al. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996; 41:172-9.
28. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95:1056-62.
29. Shiraishi K, Matsuzaki S, Ishida H, Nakazawa H. Impaired erythrocyte deformability and membrane fluidity in alcoholic liver disease: participation in disturbed hepatic microcirculation. Alcohol Alcohol Suppl 1993; 1A:59-64.
30. Nordmann R, Rouach H. [Alcohol and free radicals: from basic research to clinical prospects.] Ann Gastroenterol Hepatol (Paris) 1996; 32:128-33. French.
31. Lindenbaum J. Hematologic complications of alcohol abuse. Semin Liver Dis 1987; 7:169-81.
32. Ohtsuka T, Tsutsumi M, Fukumura A, Tsuchishima M, Takase S. Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study. Alcohol Clin Exp Res 2005; 29:236S-9S.
33. Chalmers DM, Chanarin I, MacDermott S, Levi AJ. Sex-related differences in the haematological effects of excessive alcohol consumption. J Clin Pathol 1980; 33:3-7.
34. Thiele G, Thiele J. [Significance of macrocytosis as an indicator of chronic alcohol abuse.] Z Gesamte Inn Med 1987; 42:53-6. German.
35. Wu A, Chanarin I, Levi AJ. Macrocytosis of chronic alcoholism. Lancet 1974; 1:829-31.
36. Kazemi-Shirazi L, Veloso MP, Frommlet F, et al. Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful? Wien Klin Wochenschr 2008; 120:25-30.
37. Anttila P, Järvi K, Latvala J, et al. Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity. Scand J Clin Lab Invest 2005; 65:141-51.
38. Niemelä O. Serum diagnosis of alcoholic liver disease and markers of ethanol intake. In: Sherman DIN, Preedy VR, Watson RR, eds. Ethanol and Liver. Mechanisms and Management. London: Taylor and Francis, 2002: 411-49.
39. Das SK, Nayak P, Vasudevan DM. Biochemical markers for alcohol consumption. Indian J Clin Biochem 2003; 18:111-8.
40. Das SK, Dhanya L, Vasudevan DM. Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 2008; 68:81-92.
41. Stimmel B, Korts D, Jackson G, Gilbert HS. Failure of mean red cell volume to serve as a biological marker for alcoholism in narcotic dependence. A randomized controlled trial. Am J Med 1983; 74:369-74.
42. Whitfield JB, Hensley WJ, Bryden D, Gallagher H. Some laboratory correlates of drinking habits. Ann Clin Biochem 1978; 15:297-303.
43. Helman RA, Temko MH, Nye SW, Fallon HJ. Alcoholic hepatitis: Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971; 74:311-21.
44. Aarts PA, Bolhuis PA, Sakariassen KS, Heethaar RM, Sixma JJ. Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood 1983; 62:214-7.
45. Levine RF, Spivak JL, Meagher RC, Sieber F. Effect of ethanol on thrombopoiesis. Br J Haematol 1986; 62:345-54.
46. Michot F, Gut J. Alcohol-induced bone marrow damage. A bone marrow study in alcohol-dependent individuals. Acta Haematol 1987; 78:252-7.